跳至主要内容
临床试验/NCT01370304
NCT01370304Unknown3 期

Repetitive Transcranial Magnetic Stimulation (rTMS) Compared or Associated With Venlafaxine for Depressive Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2011年6月1日最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
60
试验地点
1
主要终点
The primary outcome measure is remission

研究概览

简要总结

The purpose of this study is to treat participants with a diagnosis of depressive disorder to assess the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) and venlafaxine in the treatment of depressive disorders compared venlafaxine only (the optimal medication) and to rTMS only. fMRI will be performed to determine if treatment response is related to changes in fMRI, and use it to investigate the respondence to the treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years and older
  • Clinical diagnosis of major depressive disorder (DSM-IV)
  • HDRS-17 items > 20
  • Failure of one antidepressant treatment (efficacious doses for 6 weeks at least)

排除标准

  • Psychotic features
  • Failure of one previous venlafaxine treatment
  • Addiction comorbidity or schizophrenia comorbidity
  • Involuntary hospitalization
  • Seizures history
  • Pregnancy or breastfeeding
  • Somatic comorbidity able to impact on cognitive functions

结局指标

主要结局

The primary outcome measure is remission

时间窗: 1-6 weeks

It will be evaluated using the Hamilton Depression Rating Scale (HDRS-17 \< 8)

次要结局

  • QIDS-C30(1-6 weeks)
  • fMRI(0,6 weeks)
  • CGI(1-6 weeks)
  • UKU Scale(1-6 weeks)

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

fengshufang

Fourth Military Medical University, Department of Psychosomatics, Xijing Hospital

Xijing Hospital

研究点 (1)

Loading locations...

相似试验

Repetitive Transcranial Magnetic Stimulation... | 临床试验